RxDoctor Payments DataLook up a doctor →

Christopher Chien, MD

Advanced Heart Failure and Transplant Cardiology · Portland, ORNPI 1477732535

Payments from drug & device makers

$1,437,951in general payments, 2019–2025

Across 276 payments — averaging $5209.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • American Regent$916K
  • Abbott$331K
  • Boehringer Ingelheim$85K
  • AstraZeneca$69K
  • Boston Scientific$13K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$12K
  • plus $12K from 13 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few advanced heart failure and transplant cardiology providers in Oregonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$30,366
Medicare patients
80
Services billed
291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →